Safety evaluation of an extension of use of the food enzyme α-amylase from the non-genetically modified Bacillus amyloliquefaciens strain LMG-S 32676
The food enzyme α‐amylase (4‐α‐d‐glucan glucanohydrolase; EC 3.2.1.1.) is produced with the non‐genetically modified Bacillus amyloliquefaciens strain LMG‐S 32676 by Kerry Ingredients & Flavours Ltd. The safety of this food enzyme was evaluated previously, and it did not give rise to safety concerns when used in six food manufacturing processes. Subsequently, the applicant has requested to extend its use to include three additional processes. In this assessment, EFSA updated the safety evaluation of this food enzyme when used in a total of nine food manufacturing processes.
Read the official notice →Source: EFSA (European Food Safety Authority) · EFSA reuse policy (attribution). This is a short, attributed summary; the full authoritative text lives on the authority’s own site. LabelYog does not author or endorse it — confirm compliance against the destination market’s official source.
More from European Union
- Safety evaluation of an extension of use of the food enzyme α-amylase from the genetically modified Aspergillus niger strain NZYM-SB regulatory
- Safety evaluation of an extension of use of the food enzyme phospholipase A1 from the genetically modified Aspergillus niger strain NZYM-FP regulatory
- Safety evaluation of an extension of use of the food enzyme phospholipase A1 from the genetically modified Aspergillus oryzae strain NZYM-PP regulatory
- Episode 42 – Pesticides: the good, the bad and the ugly regulatory
- Multi-country outbreak of Salmonella Bovismorbificans ST377 infections linked to the consumption of alfalfa sprouted seeds 25 June 2026 regulatory
- Safety evaluation of an extension of use of the food enzyme α-amylase from the genetically modified Bacillus licheniformis strain NZYM-AC regulatory
What this means for your label
A notice like this changes what a pack must carry. These are the rules we build against, starting with EU 1169.